O

Organovo Holdings

D
ONVO
USD
0.018
(4.4776%)
Market Closed
1,100.00
Volume
-0.96
EPS
-
Div Yield
-0.306569
P/E
6,452,911.92
Market Cap
Today
0.0000%
1 Week
-3.470%
1 Month
-8.696%
6 Months
-54.228%
12 Months
-77.297%
Year To Date
-61.818%
All Time
-99.444%

Title:
Organovo Holdings

Sector:
Healthcare
Industry:
Biotechnology
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
Do you need help or have a question?